Key Facts

Lilly at a Glance

(as of March 31, 2021)

• A heritage more than 140 years strong: company founded on May 10, 1876

• Headquarters located in Indianapolis, Indiana, U.S.A.

• More than 34,000 employees worldwide

• Approximately 8,000 employees engaged in research and development

• Clinical research conducted in more than 55 countries

• Research and development facilities in 7 countries

• Research and development expenditure of $6,086 million USD in 2020 ($23.4 million/workday)

• Research and development as a percentage of sales in 2020: 24.8%

• Percentage of total workforce engaged in research and development in 2020: 23%

• Manufacturing plants in 7 countries

• Products marketed in 120 countries
  

Snapshot of Lilly Canada

(as of December 31, 2020)

• Founded in 1938 as a result of a collaboration between Eli Lilly and Company and Banting and Best, which produced the world’s first commercially available insulin

• Approximately 325 employees

• Managed research at 418 sites across Canada

• Almost $26.4 million CAD of research and development as acknowledged by the PMPRB, plus more than $100 million USD as part of our agreement with AbCellera
  

• More than $27.6 million in community support including grants, fellowships, charitable donations, medical education programs, sponsorship of medical and therapeutic associations, and free medicine distributed through our compassionate access programs and patient support programs
  

Cost of Pharmaceuticals

• Average cost to discover and develop a new drug: $2.6 billion USD

• Average length of time from discovery to patient: 10 years